<DOC>
	<DOCNO>NCT00110643</DOCNO>
	<brief_summary>The purpose research project study effect non-ablative ( non-cutting ) laser therapy , technique us laser energy try improve appearance skin . In study , interested learn well laser work improve symptom acne . The laser use particular study CoolTouch II® laser , manufacture ICN Photonics , Inc. , FDA-approved treatment acne .</brief_summary>
	<brief_title>Infrared Non-Cutting Laser Therapy Acne</brief_title>
	<detailed_description>The purpose research project study effect non-ablative ( non-cutting ) laser therapy , technique us laser energy try improve appearance skin . This type laser treatment create change layer skin call dermis without cause open wound skin . It yet clear much improvement see treatment exactly skin 's response cause improvement . In study , interested learn well laser work improve symptom acne . The laser use particular study CoolTouch II® laser , manufacture ICN Photonics , Inc. , FDA-approved treatment acne .</detailed_description>
	<mesh_term>Acne Vulgaris</mesh_term>
	<criteria>Age 13 year old either gender racial/ethnic group . Subjects must clinically evident acne vulgaris facial skin . Subjects must understand sign inform consent prior participation . Subjects must generally good health . Subjects must able willing comply requirement protocol . You must live within reasonable drive distance Ann Arbor , Michigan , and/or able attend schedule appointment study . Oral retinoid ( Accutane ) use within 1 year entry study . Systemic acne therapy ( oral antibiotic ) within 4 week entry study . Topical acne therapy ( retinoids , antibiotic ) within 2 week entry study . Microdermabrasion superficial chemical peel sit treat within 3 month entry study . Subjects history dermabrasion laser resurface site treat . Use topical lipid absorb substance ( Clinac AC ) within 2 week entry study . Noncompliant subject . Subjects significant medical history concurrent illness/condition investigator ( ) feel safe study participation . Subjects use alcoholbased topical solution `` exfolliating '' agent within 2 week entry study . Subjects history frequent herpes simplex infection face clinical evidence active herpes simplex infection . History keloid scar formation subject undergoing biopsy . Pregnant nursing female .</criteria>
	<gender>All</gender>
	<minimum_age>13 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>April 2015</verification_date>
	<keyword>Acne</keyword>
	<keyword>laser</keyword>
</DOC>